Shumei Kato, MD, discusses the characterization of BRAF mutations in oncology.
Shumei Kato, MD
Advertisement
Articles by Shumei Kato, MD
Advertisement
Latest Updated Articles
Dr. Kato on the Characterization of BRAF Mutations in OncologyJanuary 31st 2022
Advertisement
Advertisement
Trending on OncLive
1
MONUMENTAL-3 Data Support Talquetamab Plus Daratumumab ± Pomalidomide as a New SOC in R/R Myeloma
2
FDA Approves Capivasertib Plus Abiraterone and Prednisone for PTEN-Deficient mHSPC
3
Luspatercept Misses Primary RBC-TI End Point But Shows Clinically Meaningful Improvement for Anemia in Myelofibrosis
4
CLL14 Final Analysis Shows Long-Term PFS Gain With Venetoclax/Obinutuzumab in Previously Untreated CLL
5